Companies Mentioned

Aventis Pharmaceuticals Inc.

Category
Title
Summary
Date
Summaries
Patent Law >
New Judicial Opinions

Aventis' Patent for Lou Gehrig Disease Drug Valid, Federal Circuit Finds
The ’814 patent relates to the use of riluzole to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). Aventis Pharmaceuticals Inc. (“Aventis”) owns the ’814 patent and sells riluzole under the trade name RILUTEK. Opinion, p. 1. On May 16, 2001, Impax filed with the Food and Drug Administration…
Date of ruling:
10/3/2008